Post-Acute Withdrawal Syndrome (PAWS): Symptoms & Recovery

01Quick Answer

Post-acute withdrawal syndrome (PAWS), also called protracted withdrawal, describes symptoms such as anxiety, low mood, poor sleep and cravings that continue or appear after the acute phase of withdrawal has passed. It is not an official diagnosis, and research on how common it is and how long it lasts is limited. Reports describe symptoms lasting weeks, months or sometimes longer, depending on the substance. A clinician can help separate lingering withdrawal symptoms from an underlying mood or anxiety condition.

Most people expect withdrawal to be a short, hard stretch that ends. For some, it does not end cleanly. Sleep stays broken, mood stays flat, concentration slips, and cravings come in waves, sometimes weeks or months after the physical symptoms of withdrawal are over.

This article covers what PAWS is and is not, reported symptoms and durations, possible mechanisms, and the evidence for treatment. It distinguishes stronger evidence from uncertainty. It does not give instructions for reducing or stopping any substance or medication at home.

02What Post-Acute Withdrawal Syndrome Is And Is Not

PAWS has several names, including protracted withdrawal, post acute withdrawal syndrome, post-acute withdrawal and protracted abstinence. A SAMHSA treatment advisory uses a broad definition: substance-specific withdrawal symptoms that persist past the expected acute window, plus other symptoms that persist, change or appear later. The advisory says the DSM has no protracted withdrawal diagnosis and sets no timeframes (SAMHSA, 2010).

A 2022 systematic review of post-acute alcohol withdrawal found no consensus definition and noted that PAWS appears in neither the DSM nor ICD. Its authors called the concept credible but the evidence limited. They described the American Society of Addiction Medicine's 2020 alcohol withdrawal guideline as defining protracted withdrawal through irritability, anxiety and sleep disturbance lasting beyond 30 days, while calling for clearer definitions and symptom thresholds (Bahji et al., 2022).

PAWS is a label for a pattern clinicians describe, not a diagnosis with fixed criteria. Not everyone who stops using a substance experiences lingering symptoms. Some people improve and then experience symptoms again; intensity and duration vary (SAMHSA, 2010).

03Common PAWS Symptoms

The symptoms reported most often involve mood, sleep and thinking rather than the physical symptoms of acute withdrawal. The SAMHSA advisory lists:

• Anxiety and irritability
• Sleep problems and persistent fatigue
• Short-term memory problems
• Trouble concentrating or making decisions
• Cravings
• Difficulties with planning and impulse control
• Anhedonia, a reduced ability to feel pleasure
• Depression or dysphoria
• Unexplained physical complaints
• Reduced interest in sex

Symptoms are not identical across substances. The 2022 alcohol review describes anxiety, low mood, anhedonia, sleep disturbance, cognitive problems, cravings and irritability, with overlap with other mental-health symptoms (SAMHSA, 2010; Bahji et al., 2022).

04How Long PAWS Symptoms Last By Substance

Duration is one of the less certain parts of the evidence. These reports come from a mixture of small and older studies. They are not predictions for an individual.

Acute withdrawal timelines for individual substances are on the Withdrawal Page. PAWS describes symptoms that can persist or appear after that stage.

Benzodiazepine withdrawal can involve seizures and other serious reactions. The FDA warns that abrupt discontinuation or reducing a dose too quickly can cause potentially life-threatening withdrawal. There is no standard tapering schedule suitable for every patient; this article provides no taper instructions (FDA, 2020).

05Why Prolonged Withdrawal Symptoms Happen

The mechanism is not settled. SAMHSA describes brain changes from chronic substance use that can persist beyond acute withdrawal, with anhedonia as one example (SAMHSA, 2010).

The 2022 alcohol review discusses possible biological features including altered brain electrical responses, stress-hormone activity, serotonin pathways and glutamate changes. Some findings were inconsistent or returned toward normal over time. Its authors also question whether some symptoms reflect an untreated mood, anxiety or cognitive disorder rather than withdrawal alone (Bahji et al., 2022).

06PAWS, Relapse Risk And Co-Occurring Conditions

Craving is one of the most studied persistent symptoms after alcohol withdrawal. A 2023 systematic review covered 102 publications on craving, sleep problems and anhedonia: 70 randomized trials and 32 cohort studies. It concerned protracted alcohol withdrawal and selected symptoms, not PAWS across all substances (2023 review).

SAMHSA advises assessment and reassessment of co-occurring disorders, depression and suicidality during recovery. Low mood, anxiety and poor sleep can reflect lingering withdrawal, a pre-existing mental-health condition, or both. Clinical assessment matters because the appropriate care depends on the cause (SAMHSA, 2010). The Dual Diagnosis Treatment Guide explains integrated substance-use and mental-health care.

07What The Evidence Says About Treatment

PAWS-specific treatment research is limited. Much of the available evidence concerns clinical guidance or particular symptoms rather than a defined syndrome.

This table is not a treatment plan or a medication recommendation. Prescribing decisions require individual assessment. There are reasonable clinical approaches to persistent symptoms, but most are not backed by trials aimed at PAWS itself, and evidence for sleep and anhedonia remains sparse.

08What Recovery From PAWS Looks Like Over Time

For many people, symptoms ease with time. SAMHSA describes recovery as a process and notes that some people improve before symptoms recur. The alcohol review describes continuing improvement in mood symptoms in some long-term observations, but this does not mean PAWS normally lasts for that entire period (SAMHSA, 2010; Bahji et al., 2022).

A slow stretch is not necessarily a sign of failure. Persistent or changing symptoms warrant assessment rather than automatically being attributed to PAWS. SAMHSA recommends monitoring during continuing care. The Aftercare Guide explains what continuing support can include.

09Recovery Supports In Federal Facility Records

Prolonged symptoms may be addressed during continuing substance-use or mental-health care. The Levels Of Care Guide explains how Partial Hospitalization, Intensive Outpatient Programs and Standard Outpatient Care differ. These are levels of broader treatment, not PAWS-specific programs. Assessment determines appropriate care; acute withdrawal is a different stage, discussed in the Detox Guide.

Our analysis of 11,650 federally listed program records shows how widely related services are reported:

Source: Treatment Locators analysis of federal facility-reported records, dataset refreshed September 20, 2026. Programs can report multiple levels of care and are counted once in the combined outpatient/IOP figure. Medication treatment means the dataset's medication-assisted treatment label, not psychiatric medication management. These service reports are not PAWS prevalence or treatment-outcome statistics, and they do not establish current availability, quality, or suitability for a particular person.